An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: A study protocol

American Journal of Translational Research

Volumn 4, Issue 1, 2012, Pages 52-59

  Morimoto, Naoki ^a   Yoshimura, Kenichi ^b   Niimi, Miyuki ^b   Ito, Tatsuya ^b   Tada, Harue ^b   Teramukai, Satoshi ^b   Murayama, Toshinori ^b   Toyooka, Chikako ^b   Takemoto, Satoru ^a   Kawai, Katsuya ^a   Yokode, Masayuki ^b   Shimizu, Akira ^b   Suzuki, Shigehiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Artificial dermis; Basic fibroblast growth factor; Skin ulcers; Sustained release

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR 2; GELATIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ARTIFICIAL SKIN; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; DEBRIDEMENT; DRUG EFFICACY; DRUG SAFETY; EPITHELIZATION; FOLLOW UP; GRANULATION TISSUE; HUMAN; LOW DRUG DOSE; MALE; RANDOMIZED CONTROLLED TRIAL; SKIN ULCER; TISSUE ENGINEERING; WOUND; WOUND HEALING IMPAIRMENT;

EID: 84863412751     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vuorisalo S, Venermo M, Lepäntalo M. Treatment of diabetic foot ulcers. J Cardiovasc Surg (Torino) 2009; 50: 275-291.
2. Bergqvist D, Lindholm C, Nelzen O. Chronic leg ulcers: the impact of venous disease. J Vasc Surg 1999; 29: 752-755.
3. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228.
4. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 2007; 3: 65-76.
5. Ehrenreich M, Ruszczak Z. Update on tissueengineered biological dressings. Tissue Eng 2006; 12: 2407-2424.
6. Mason C, Manzotti E. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Regen Med 2010; 5: 307-313.
7. Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R, Tamaki K, Hirakata H, Ohmura T, Furue M. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 2009; 19: 461-468.
8. Trier WC, Peacock EE Jr, Madden JW. Studies on the effectiveness of surgical management of chronic leg ulcers. Plast Reconstr Surg 1970; 45: 20-23.
9. Suzuki S, Matsuda K, Issiki N, Tamada Y, Ikada Y. Experimental study of a newly developed bilayer artificial skin. Biomaterials 1990; 11: 356-360.
10. Suzuki S, Matsuda K, Isshiki N, Tamada Y, Yoshioka K, Ikada Y. Clinical evaluation of a new bilayer 'artificial skin' composed of collagen sponge and silicone layer. Br J Plast Surg 1990; 43: 47-54.
11. Yannas IV, Orgill DP, Burke JF. Template for skin regeneration. Plast Reconstr Surg 2011; 127: 60S-70S.
12. Yannas IV, Burke JF. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 1980; 14: 65-81.
13. Gospodarowicz D. Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 1974; 249: 123-127.
14. Hom DB, Unger GM, Pernell KJ, Manivel JC. Improving surgical wound healing with basic fibroblast growth factor after radiation. Laryngoscope 2005; 115: 412-422.
15. Akita S, Akino K, Imaizumi T, Hirano A. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen 2008; 16: 635-641.
16. Muneuchi G, Suzuki S, Moriue T, Igawa HH. Combined treatment using artificial dermis and basic fibroblast growth factor (bFGF) for intractable fingertip ulcers caused by atypical burn injuries. Burns 2005; 31: 514-517.
17. Akita S, Akino K, Tanaka K, Anraku K, Hirano A. A basic fibroblast growth factor improves lower extremity wound healing with a porcine-derived skin substitute. J Trauma 2008; 64: 809-815.
18. Ito K, Ito S, Sekine M, Abe M. Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor. Plast Reconstr Surg 2005; 115: 567-572
19. Fujioka M. Combination treatment with basic fibroblast growth factor and artificial dermis improves complex wounds in patients with a history of long-term systemic corticosteroid use. Dermatol Surg 2009; 35: 1422-1425.
20. Takemoto S, Morimoto N, Kimura Y, Taira T, Kitagawa T, Tomihata K, Tabata Y, Suzuki S. Preparation of collagen/gelatin sponge scaffold for sustained release of bFGF. Tissue Eng Part A 2008; 14: 1629-1638.
21. Kanda N, Morimoto N, Takemoto S, Ayvazyan AA, Kawai K, Sakamoto Y, Taira T, Suzuki S. Efficacy of Novel Collagen/Gelatin Scaffold With Sustained Release of Basic Fibroblast Growth Factor for Dermis-like Tissue Regeneration. Ann Plast Surg 2011. [Epub ahead of print]
22. Ayvazyan AA, Morimoto N, Kanda N, Kawai K, Sakamoto Y, Taira T, Suzuki S. Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs. J Surgical Res 2011; 171: 247-257.
23. Langer A, Rogowski W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res 2009; 9: 115.
24. O'Reilly D, Linden R, Fedorko L, Tarride JE, Jones WG, Bowen JM, Goeree R. A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. Trials 2011; 12: 69.
25. Wong T, McGrath JA, Navsaria H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 2007; 156: 1149-1155.
26. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 2009; 122: 3209-3213.
27. Martin P. Wound Healing-Aiming for Perfect Skin Regeneration. Science 1997; 276: 75-81.
28. Sanada H, Moriguchi T, Miyachi Y, Ohura T, Nakajo T, Tokunaga K, Fukui M, Sugama J, Kitagawa A. Reliability and validity of DESIGN, a tool that classifies pressure ulcer severity and monitors healing. J Wound Care 2004; 13: 13- 18.
29. Lavery LA, Barnes SA, Keith MS, Seaman JW Jr, Armstrong DG. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. Diabetes Care 2008; 31: 26-29.
30. Japanese Society of Pressure Ulcers. Guideline for Local Treatment of Pressure Ulcers 2005.
31. Japanese Society of Pressure Ulcers. Guideline for Prevention and Management of Pressure Ulcers. 2009.
32. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24: 290-295.
33. Cardinal M, Eisenbud DE, Armstrong DG, Zelen C, Driver V, Attinger C, Phillips T, Harding K. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 2009; 17: 306-311.
34. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366: 1704-1710.